These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 5096324)

  • 1. [Effects of oxyfedrin on hemodynamics and myocardial and hepatic metabolism in dogs].
    Niessner H; Raberger G; Lujf A; Moser K
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 155(4):304-14. PubMed ID: 5096324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of oxyfedrin on hemodynamics and myocardial and hepatic metabolism in intact dogs after beta-adrenergic blockade].
    Niessner H; Raberger G; Lujf A; Moser K
    Res Exp Med (Berl); 1972; 158(4):288-97. PubMed ID: 5085437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies of the modification of myocardial metabolism with oxyfedrin].
    Niessner H; Lujf A; Moser K
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(2):163-74. PubMed ID: 5357616
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of heptaminol hydrochloride on general, pulmonary and coronary hemodynamics and its effect on heart metabolism].
    Pourrias B; Sergant M; Raynaud G
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):190-6. PubMed ID: 5425959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of glucagon on cardiac hemodynamics, coronary circulation and myocardial metabolism in humans].
    Warembourg H; Houdas Y; Bertrand ME; Ketelers JY; Vermeersch M
    Arch Mal Coeur Vaiss; 1969 Aug; 62(8):1080-95. PubMed ID: 4983769
    [No Abstract]   [Full Text] [Related]  

  • 6. [The metabolism of the fibrillating human heart in maintained coronary circulation. II. Studies on the substrate supply of the myocardium during extracorporeal circulation].
    Rudolph W; Sebening F; Klinner W; Kriener J
    Z Kreislaufforsch; 1967 Aug; 56(8):775-95. PubMed ID: 5592703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myocardial oxygen and substrate metabolism in patients with aortic valve stenosis].
    Rudolph W; Wicklmayr M
    Z Kreislaufforsch; 1969 Mar; 58(3):252-66. PubMed ID: 5772011
    [No Abstract]   [Full Text] [Related]  

  • 8. General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):226-31. PubMed ID: 5657822
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of acute catecholamine release by guanoxan upon the myocardial metabolism of the intact dog.
    Maxwell GM; Kneebone GM
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):149-56. PubMed ID: 5709780
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic effects following a short and medium chain triglycerides load in dogs. II. Influence of the infused fat quantity.
    Guisard D; Bach A; Debry G; Metais P
    Arch Sci Physiol (Paris); 1972; 26(2):195-205. PubMed ID: 4650831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contractility and dynamics of the heart after Oxyfedrin and propranolol].
    Stauch M; Härich BK
    Arztl Forsch; 1971 Apr; 25(4):101-9. PubMed ID: 4396526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Substrate metabolism of the human heart modified by glucagon].
    Rudolph W; Jehle J
    Klin Wochenschr; 1973 Feb; 51(3):116-22. PubMed ID: 4687518
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differencies in the substrate metabolism of the healthy and sick heart].
    Keul J; Doll E
    Arztl Forsch; 1968 Mar; 22(3):104-8. PubMed ID: 5755314
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of ATP on myocardial metabolism in non-anesthetized dogs].
    Marchetti G; Merlo L; Noseda V; Ferrini R; Marzo A
    Boll Soc Ital Cardiol; 1969; 14(5):587-92. PubMed ID: 5385617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic and clinical studies of the coronary therapeutic agent oxyfedrin].
    Krosch H; Rikirsch P; Schäbitz J; Teichmann W
    Z Arztl Fortbild (Jena); 1972 Jun; 66(11):557-62. PubMed ID: 5072115
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of streptozotocin on carbohydrate and lipid metabolism in the rat.
    Schein PS; Alberti KG; Williamson DH
    Endocrinology; 1971 Sep; 89(3):827-34. PubMed ID: 4327777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a new beta-receptor blocking substance on human hemodynamics and metabolism].
    Niessner H; Lujf A; Moser K
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):277-81. PubMed ID: 4394123
    [No Abstract]   [Full Text] [Related]  

  • 18. Arterial levels, cardiac and hepatic arteriovenous differences, extraction coefficients and oxygen extraction ratios of various substrates in normal, and in acute and chronic alloxan-diabetic dogs.
    Kraupp O; Adler-Kastner L; Kolassa N; Nell G; Plank B; Chirikdjian JJ
    Eur J Biochem; 1968 Oct; 6(1):114-25. PubMed ID: 5725804
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the substrate supply of the human heart in dependence on nutrient intake].
    Müller-Seydlitz PM; Hauer G; Dietze G; Baubkus H; Zeitlmann F; Gadomski M; Rudolph W
    Verh Dtsch Ges Inn Med; 1969; 75():376-80. PubMed ID: 5400158
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of L- and DL-oxyfedrin].
    Hüller H; Amon I; Peters R; Schmidt D
    Pharmazie; 1972 Apr; 27(4):242-5. PubMed ID: 4403335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.